このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Mangalam Drugs & Organics バランスシートの健全性
財務の健全性 基準チェック /36
Mangalam Drugs & Organicsの総株主資本は₹1.4B 、総負債は₹964.5Mで、負債比率は71%となります。総資産と総負債はそれぞれ₹3.3Bと₹2.0Bです。 Mangalam Drugs & Organicsの EBIT は₹27.5Mで、利息カバレッジ比率0.2です。現金および短期投資は₹9.1Mです。
主要情報
71.0%
負債資本比率
₹964.49m
負債
| インタレスト・カバレッジ・レシオ | 0.2x |
| 現金 | ₹9.11m |
| エクイティ | ₹1.36b |
| 負債合計 | ₹1.98b |
| 総資産 | ₹3.33b |
財務の健全性に関する最新情報
Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29
These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01
Recent updates
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
May 23Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding
Mar 28Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business
Feb 07Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Oct 20Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Apr 06We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?
Nov 12A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Sep 20Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?
Aug 05We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01財務状況分析
短期負債: MANGALAMの 短期資産 ( ₹1.8B ) が 短期負債 ( ₹1.6B ) を超えています。
長期負債: MANGALAMの短期資産 ( ₹1.8B ) が 長期負債 ( ₹338.5M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: MANGALAMの 純負債対資本比率 ( 70.4% ) は 高い と見なされます。
負債の削減: MANGALAMの負債対資本比率は、過去 5 年間で65.7%から71%に増加しました。
債務返済能力: MANGALAMの負債は 営業キャッシュフロー によって 十分にカバー されています ( 41% )。
インタレストカバレッジ: MANGALAMの負債に対する 利息支払い は EBIT ( 0.2 x coverage) によって 十分にカバーされていません。